Images in Haematology
Liposomal cytarabine in cerebrospinal fluid
Kevin Boyd, Matthew Jenner, Jennie Treleaven, Jackie Kenny, Elaine Rhoades
p.679
Unexpected glucose-6-phosphate dehydrogenase deficiency
Wing-Yan Au, Jovic Tse, Jason C. C. So, Thomas S. K. Wan, Karl Young
p.680
Reviews
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma
Sagar Lonial, Jamie Cavenagh
p.681-708
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions
Helen Chapel, Charlotte Cunningham-Rundles
p.709-727
Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis – a personal view
Robert F. Schilling
p.728-732
Haematological Malignancy
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
Monica Else, Claire E. Dearden, Estella Matutes, Juan Garcia-Talavera, Ama Z. S. Rohatiner, Steve A. N. Johnson, Nigel T. J. O'Connor, Andy Haynes, Nnenna Osuji, Francesco Forconi, Francesco Lauria, Daniel Catovsky
p.733-740
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas
Jennifer R. Brown, Jonathan W. Friedberg, Yang Feng, Sarah Scofield, Kimberly Phillips, Paola Dal Cin, Robin Joyce, Ronald W. Takvorian, David C. Fisher, Richard I. Fisher, Jane Liesveld, Diana Marquis, Donna Neuberg, Arnold S. Freedman
p.741-748
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study
Wendy Ingram, Lucas Chan, Hayrettin Guven, David Darling, Shahram Kordasti, Nicola Hardwick, Linda Barber, Ghulam J. Mufti, Farzin Farzaneh
p.749-760
The protein kinase C agonist PEP005 increases NF-B expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells
Astrid Marta Olsnes, Elisabeth Ersvær, Anita Ryningen, Kristin Paulsen, Peter Hampson, Janet M. Lord, Bjørn Tore Gjertsen, Einar Klæboe Kristoffersen, Øystein Bruserud
p.761-774
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease
Angela Pennisi, Xin Li, Wen Ling, Sharmin Khan, Dana Gaddy, Larry J. Suva, Bart Barlogie, John D. Shaughnessy, Nazneen Aziz, Shmuel Yaccoby
p.775-787
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Véronique Gelsi-Boyer, Virginie Trouplin, José Adélaïde, Julien Bonansea, Nathalie Cervera, Nadine Carbuccia, Arnaud Lagarde, Thomas Prebet, Meyer Nezri, Danielle Sainty, Sylviane Olschwang, Luc Xerri, Max Chaffanet, Marie-Joëlle Mozziconacci, Norbert Vey, Daniel Birnbaum
p.788-800
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate
Julio Delgado, Guy Pratt, Neil Phillips, Javier Briones, Chris Fegan, Josep Nomdedeu, Chris Pepper, Anna Aventin, Ramon Ayats, Salut Brunet, Rodrigo Martino, David Valcarcel, Donald Milligan, Jorge Sierra
p.801-805
Paediatric
Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing
Piya Rujkijyanont, Sally-Lin Adams, Joseph Beyene, Yigal Dror
p.806-815
Transplantation
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation
Voravit Ratanatharathorn, Brent Logan, Dan Wang, Mary Horowitz, Joseph P. Uberti, Olle Ringden, Robert Peter Gale, Hanna Khoury, Mukta Arora, Stephen Spellman, Corey Cutler, Joseph Antin, Martin Bornhaüser, Gregory Hale, Leo Verdonck, Mitchell Cairo, Vikas Gupta, Steven Pavletic
p.816-824
Platelets, Haemostasis and Thrombosis
A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study
Yesim Dargaud, Lucia Rugeri, Marie Christine Vergnes, Brigitte Arnuti, Paula Miranda, Claude Negrier, Audrey Bestion, Hélène Desmurs-Clavel, Jacques Ninet, Pascal Gaucherand, Rene Charles Rudigoz, Michel Berland, Fabienne Champion, Marie Christine Trzeciak
p.825-835
VEGF/KDR loop is a target of AG1296 in acute myeloid leukaemia showing FLT3-internal tandem duplications
Luis Arístides Torres, Nuria Barbarroja, Gabriel Dorado, Francisco Velasco, Chary López-Pedrera
p.836-838
Is 'Virchow's triad' useful?
Padraic Colm Malone, Paul S. Agutter
p.839
Is 'Virchow's triad' useful? – response to Malone and Agutter
Catherine N. Bagot, Roopen Arya
p.840-841
A new VKORC1 mutation leading to an isolated resistance to fluindione
Katell Peoc'h, Sandrine Pruvot, Céline Gourmel, Claire Bal dit Sollier, Ludovic Drouet
p.841-843
Hb Southern Italy: coexistence of two missence mutations (the Hb Sun Prairie  2 130 Ala > Pro and Hb Caserta  2 26 Ala > Thr) in a single HBA2 gene
Giuseppina Lacerra, Clementina Carestia
p.843-844 |
